ResQ Biotech is a spin-off company of the National Research Foundation (NRF), founded in 2019 in the Patras Science Park. The company applies innovative biotechnological approaches to research and preclinical drug development against protein misfolding diseases, such as Alzheimer’s and Parkinson’s disease, ALS, cystic fibrosis and systemic amyloidosis.

The internationally known Dane investor’s decision is the second private financing to the company after that by ‘Blue Dome Capital’ in 2022.